קסלודה 150 מ"ג

国: イスラエル

言語: ヘブライ語

ソース: Ministry of Health

有効成分:

CAPECITABINE 150 MG

から入手可能:

ROCHE PHARMACEUTICALS (ISRAEL) LTD

ATCコード:

L01BC06

医薬品形態:

FILM COATED TABLETS

投与経路:

PER OS

製:

HOFFMANN LA ROCHE LTD, SWITZERLAND

治療群:

CAPECITABINE

適応症:

Adjuvant Colon Cancer: Xeloda is indicated for the adjuvant treatment of patients following surgery of stage III (Dukesע stage C) colon cancer. Colorectal Cancer: Xeloda is indicated for the treatment of patients with advanced or metastatic colorectal cancer Advanced gastric cancer: Xeloda is indicated for first line treatment of advanced gastric cancer in combination with chemotherapy Breast Cancer Combination Therapy: Xeloda in combination with docetaxel is indicated for the treatment of patients with metastatic breast cancer after failure of prior anthracycline-containing chemotherapy. Breast Cancer Monotherapy: Xeloda is also indicated for the treatment of advanced or metastatic breast cancer after failure of standard therapy including a taxane unless therapy with a taxane is clinically contraindicated.

承認日:

2010-06-01